NOVEL AMIDE DERIVATIVE FOR INHIBITING GROWTH OF CANCER CELLS Russian patent published in 2011 - IPC C07D403/12 C07D239/94 A61K31/517 A61P35/00 

Abstract RU 2434010 C2

FIELD: chemistry.

SUBSTANCE: invention relates to novel amide derivatives of formula (I), isomers and pharmaceutically acceptable salt thereof, which have cancer cell selective inhibiting properties, caused by an epidermal growth factor receptor (EGFR), selected from EGFR or caused by EGFR mutation. In formula (I): (I) (a) or (b), A denotes a group (a) or (b), R4, R5, R6 and R7, each independently denote hydrogen, halogen, N-C1-6alkyl or N-hydroxyamido or inverse C-C1-6alkylamido (-NHCOC1-6alkyl), hydroxycarbonyl(-COOH), C1-6 alkyloxycarbonyl(-COOC1-6), C1-6alkyl or C1-6alkyl, substituted with a hydroxy group, C1-6dialkylamino or a saturated 5-6-member heterocyclic group with 1-2 heteroatoms and selected from nitrogen and oxygen atoms; R1 denotes a phenyl or a 6-member heteroaryl group with a nitrogen atom as a heteroatom, each of which is substituted with 1-3 X, or C1-6alkyl, substituted with a phenyl, which can be substituted with halogen atoms; R2 denotes hydrogen, hydroxy, C1-6alkoxy or C1-6alkoxy, substituted C1-6alkoxy or 5-6-member saturated heterocyclic group; R3 denotes hydrogen, -COOH, C1-6alkyloxycarbonyl or amido, N-unsubstituted or N-substituted Y; na and nb each is a whole number ranging from 1 to 3; where: X denotes hydrogen, halogen, hydroxy, cyano, nitro, (mono-, di- or trihalogen)methyl, mercapto, C1-6alkylthio, acrylamido, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C1-6alkoxy, phenyloxy, C1-6dialkylamino or C1-6alkyl or C1-6alkoxy, substituted with Z, provided that when the number of substitutes X equals two or more, groups X can be condensed with each other to form a 5-member cyclic structure, possibly containing 2 nitrogen atoms in the ring as heteroatoms; Y denotes hydroxy, C1-6alkyl or C1-6alkyl substituted with Z, C1-6alkyl has 1-4 fragments selected from a group consisting of N, O, S, SO and SO2; and Z denotes C1-6alkyl, phenyl or a 6-member heterocyclic group containing one or more heteroatoms selected from N or O. Said phenyl or heterocyclic group is unsubstituted or substituted with a halogen.

EFFECT: improved properties of the derivatives.

4 cl, 7 tbl, 144 ex

Similar patents RU2434010C2

Title Year Author Number
QUINAZOLINE DERIVATIVES FOR SLOWING DOWN GROWTH OF CANCER CELLS AND METHOD OF OBTAINING THEM 2005
  • Kham Jang Dzin
  • Gong Dzi Khieon
  • Cha Mi Jang
  • Kim Dzong Voo
  • Kim Maeng Sup
  • Kim Eun Jang
  • Song Dzi Jeon
  • Kim Chang In
  • Kim Se Jang
  • Li Gvan Sun
RU2362773C2
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY 2011
  • Cha Mi Yang
  • Kang Seok Dzong
  • Kim Mi Ra
  • Li Dzu Jeon
  • Dzeon Dzi Yang
  • Dzo Mioung Gi
  • Kvak Eun Dzoo
  • Li Kvang Ok
  • Kha Tae Khee
  • Sukh Kvee Khiun
  • Kim Maeng Sup
RU2585177C2
METHOD OF OBTAINING HYDROCHLORIDE OF 1-(3,4-DICHLORO-2-FLUOROPHENYLAMINO)-7-METHOXYQUINAZOLIN-6-YLOXY)PIPERIDIN-1-YL)PROP-2-EN-1-ONE AND INTERMEDIATE COMPOUNDS, APPLIED IN IT 2012
  • Bang Keuk Chan
  • Moon Joung Kho
  • Chang Joung Kil
RU2563630C1
THIENO[3,2-d]PYRIMIDINE DERIVATIVES, POSSESSING INHIBITING ACTION WITH RESPECT TO PROTEINKINASE 2011
  • Son Dzung Beom
  • Dzung Seung Khiun
  • Choj Va Il
  • Dzung Joung Khee
  • Choj Dzae Jul
  • Song Dzi Jeon
  • Li Kiu Khang
  • Li Dzae Chul
  • Kim Eun Joung
  • Akhn Jung Gil
  • Kim Maeng Sup
  • Choj Khvan Geun
  • Sim Tae Bo
  • Kham Joung Dzin
  • Park Dong-Sik
  • Kim Khvan
  • Kim Dong-Vook
RU2524210C2
ORALLY BIOAVAILABLE PRODRUGS OF (+)-3-HYDROXYMORPHINAN FOR PREVENTING OR TREATING PARKINSON'S DISEASE 2008
  • Li Dzinkhva
  • Kim Dzeongmin
  • Dzung Miung Ehun
  • Kim Dzong Jup
  • Song Kvang-Seop
  • Son Ehun Dzung
  • Li Suk Kho
  • Khan Kho Kiun
  • Kim Min Dzu
  • Li Minvoo
RU2430089C2
PYRAZOLOPYRIMIDINE DERIVATIVES AS A KINASE INHIBITOR 2017
  • Kim, In Woo
  • Han, Mi Ryeong
  • Yoo, Jakyung
  • Oh, Yun Ju
  • Kim, Ji Duck
  • Kim, Nam Youn
  • Jun, Sun Ah
  • Lee, Jun Hee
  • Park, Joon Seok
RU2714206C1
ANTIINFECTIVE COMPOUNDS 2011
  • No Zaesung
  • Kim Dzaeseung
  • Broden Prisij
  • Seo Min Dzung
  • Kim Joung Mi
  • Cheketto Dzhonatan
  • Dzeon Kheekioung
  • Zhenovezo Ogjust
  • Li Saeieon
  • Kang Sunkhee
  • Evann Fanni Ann
  • Nam Dzi Joun
  • Kristof Terri
  • Fenisten Deni Filipp Sedrik
  • Dzamung Kheo
  • Dzijeon Dzang
RU2576662C2
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY 2011
  • Cha Mi Yang
  • Kang Seok Dzong
  • Kim Mi Ra
  • Li Dzu Jeon
  • Dzeon Dzi Yang
  • Dzo Mioung Gi
  • Kvak Eun Dzoo
  • Li Kvang Ok
  • Kha Tae Khee
  • Sukh Kvee Khiun
  • Kim Maeng Sup
RU2598852C2
GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT 2008
  • Kim Soon Kha
  • Li Sung Bae
  • Joon Seung Khiun
  • Cho Mi Kioung
  • Kim Kioung Khee
  • Park Kheui Sul
  • Kim Khioung Dzin
RU2450001C2
NEW PYRIDINE DERIVATIVES, METHOD FOR MAKING THEREOF AND RELATED PHARMACEUTICAL COMPOSITION 2004
  • Kim Khiung-Ook
  • Li Nam Kiu
  • Kim Dzoo Khion
  • Rkhee Khae In
  • Cho Jong-Baik
  • Riu Dze Kho
  • Kim Nam Kho
  • Riu Keun Kho
  • Ji Dzung Bum
  • Dzung Dzae Joon
RU2366659C2

RU 2 434 010 C2

Authors

Li Kvang-Ok

Cha Mi Joung

Kim Mi Ra

Dzung Joung Khee

Li Chang Gon

Kim Se Joung

Bang Keukchan

Park Bum Voo

Choi Bo Im

Chae Jun Dzung

Ko Mi Joung

Kim Khan Kiong

Akhn Joung-Gil

Kim Maeng Sup

Li Gvan Sun

Dates

2011-11-20Published

2008-06-05Filed